Encompass Health Corp - FORM 8-K - EX-99.1 - EXHIBIT 99.1

file	filename
8-K - FORM 8-K - Encompass Health Corp	form8k_12142011.htm

Volume:

• Expect 1.0% to 2.0% discharge growth in Q4 2011

− Strong volume comparison in Q4 2010 of 5.9%

• Would bring full-year discharge growth to between 4.9% and 5.2%

Guidance confirmation for full year 2011:

• Full-year Adjusted EBITDA (1) guidance of $450 million to $455 million

• Full-year earnings per share guidance of $1.18 to $1.23 per basic share

Adjusted Free Cash Flow (1) :

• Expect full-year adjusted free cash flow to be at least $210 million

Q4 2011 Observations (as of December 14, 2011)

(1) Reconciliation to GAAP provided on slides 49, 88, and 89 of the Q3 2011 Investor Reference Book

Exhibit 99.1

Encompass Health Corp - FORM 8-K - EX-99.1 - EXHIBIT 99.1 - December 14, 2011